Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-10 Sale |
2025-03-12 7:26 pm |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
1,240 | $0.615 | $763 | 506,806 (Direct) |
View |
2025-02-03 Sale |
2025-02-05 5:30 pm |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
351 | $0.78 | $274 | 316,796 (Direct) |
View |
2024-11-04 Sale |
2024-11-05 4:59 pm |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
283 | $1.227 | $347 | 317,147 (Direct) |
View |
2024-08-05 Sale |
2024-08-07 4:06 pm |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
289 | $1.827 | $528 | 334,041 (Direct) |
View |
2024-05-03 Sale |
2024-05-07 5:13 pm |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
257 | $3.106 | $798 | 317,323 (Direct) |
View |
2024-02-05 Sale |
2024-02-07 5:21 pm |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
1,200 | $4.1409 | $4,969 | 303,580 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-11 Option Award |
2025-03-12 7:26 pm |
N/A 2035-03-11 |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
95,625 | $0 | 506,806 (Direct) |
View |
2024-11-01 Tax Withholding |
2024-11-05 4:59 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
16,611 | $1.26 | 317,147 (Direct) |
View |
2024-06-07 Option Award |
2024-06-10 4:36 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
17,007 | $0 | 334,330 (Direct) |
View |
2024-03-07 Option Award |
2024-03-11 7:38 pm |
N/A 2034-03-07 |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
95,000 | $0 | 398,580 (Direct) |
View |
2023-11-01 Tax Withholding |
2023-11-03 4:04 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
16,611 | $1.49 | 304,780 (Direct) |
View |
2023-05-15 Option Award |
2023-05-17 4:33 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
120,846 | $0 | 321,391 (Direct) |
View |
2023-02-02 Option Award |
2023-02-06 6:52 pm |
N/A 2033-02-02 |
Century Therapeutics Inc. | IPSC | Carr Douglas VP Finance & Operations |
97,500 | $0 | 290,545 (Direct) |
View |
2022-01-25 Option Award |
2022-01-27 4:49 pm |
N/A 2032-01-25 |
Century Therapeutics Inc. | IPSC | Carr Douglas VP of Finance and Operations |
35,000 | $0 | 35,000 (Direct) |
View |
Ownership |
2021-06-17 5:01 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Carr Douglas VP Finance & Operations |
0 | $0 | 219,327 (Direct) |
View |